Quantus

PeopleBio stock price

KRX:304840 · KOSDAQ · Healthcare · sector #21
₩1,586+41.35%Nov 20 close
Loading chart…

PeopleBio's chart data is dated 2026-11-20. Recorded technical signals: Short-term golden cross (5/20), Bollinger breakout. The display ticker is 304840.

  • PeopleBio's 52-week range runs from ₩1,220 to ₩4,882. The latest close of ₩1,586 is near the bottom of that range (−67.5% from the high).
  • By close, the price moved +30.0% over 1 month, +30.0% over 3 months, −42.1% over 6 months, −59.8% over 1 year.
  • Technical signals currently flagged: Short-term golden cross (5/20), Bollinger breakout.

PeopleBio Talk · Newest

For account, order or payment questions, please send a 1:1 inquiry · 1:1 inquiry →

Loading Talk…

PeopleBio last closed at ₩1,586 (+41.35%) on 2026-11-20. Signals today: Short-term golden cross (5/20), Bollinger breakout. Listed on KOSDAQ. 4 quarters to Q2 2026 PER is -2.6×. Its overall grade ranks 258 of 353 stocks in Healthcare.

PeopleBio overview

PeopleBio is listed on KOSDAQ and classified in the Healthcare sector. Its market capitalization is about KRW 39.8B. PER -2.6× and PBR 1.38× on the latest published figures. Trading records run from 2025-11-13 to 2026-11-20, a full year or more.

Revenue shrank from KRW 4.45B in 2022 to KRW 3.73B in 2024 (−16%). The company reported an operating loss of −KRW 11.58B in 2024.

Position within its sector

Among 353 stocks in Healthcare, PeopleBio ranks No. 258 on the overall grade (C), within the top 73% of its sector.

By factor, valuation (B+, top 33%) and growth (B, top 42%) stand out the most, while financial quality (F, top 93%) is the weakest of the 5.

Grades are relative positions within the same sector, shown for reference only.

About this company

Quantus's relationship data lists competitors: Samsung Electronics, Samsung SDS, NAVER; customers: Microsoft, Alphabet Class A, Amazon Com and 4 more; suppliers: NVIDIA, Advanced Micro Devices, Intel Corporation and 1 more.

By revenue it ranks No. 290 of the 321 companies with revenue data in Healthcare, with less than 0.1% of the sector's total revenue.

The sector is fragmented: its top three companies hold 16.2% of revenue.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall C · 258/353

Valuation grade B+

Details →

Recent filings

DART · received recent list, not a complete filing history. Factual information, not investment advice.

Details →

Related stocks

Details →
About PeopleBio
What technical signals does PeopleBio (304840) have?
PeopleBio current technical signals: golden cross (5_20, 0d ago).
What published figures are available for PeopleBio?
Market cap: KRW 39.8B. 4 quarters to Q2 2026 PER: -2.6×. Latest quarter PBR: 1.38×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-11-21 dataset

Turn what you saw on this name into a strategy

Ask Q about PeopleBio, or open the plan table on the main site.

Ask Q about PeopleBio.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

PeopleBio:“What if I buy at RSI 30?” 1 free card

PeopleBio notifications

Quantus Signal · live data · not investment advice · Privacy Policy